Home
Conditions
Urinary Bladder Diseases

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,285 public trials 413 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Active, Not Recruiting

Efficacy Of Pulsed Electromagnetic Field Therapy On Neurogenic Bladder in Children With Myelomeningocele

NCT04187027

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations: South Valley University, Faculty of Physical Therapy Qina, Qena Governorate, Egypt

Faculty of Physical Therapy, Outpatient Clinic Qina, Qena Governorate, Egypt

View Trial Details

Active, Not Recruiting

Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer

NCT06059547

Conditions: Adult Solid Tumor, Bladder Cancer, Female Urogenital Diseases, +10 more
Locations: IRCCS Ospedale San Raffaele Hospital Vita-Salute San Raffaele University Milan, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Oncologia Medica Roma, Italy

A.O.U. Città della Salute e della Scienza di Torino Torino, Italy

View Trial Details

Active, Not Recruiting

DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy

NCT07265414

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: IRCCS Humanitas Research Hospital Milan, Italy

View Trial Details

Active, Not Recruiting

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

NCT05768347

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

NCT02869217

Conditions: Adnexal Diseases, Bladder Cancer, Digestive System Diseases, +52 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Deprescribing dRrugs for Overactive Bladder in General Practice (DROP)

NCT06110975

Conditions: Deprescribing, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Aalborg University Hospital Aalborg, Denmark

View Trial Details

Active, Not Recruiting

Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation

NCT05975307

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations: Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations: Shalby Hospital Ahmedabad, Gujarat, India

National Cancer Institute Jhajjar, Haryana, India

All India Institute of Medical Sciences New Delhi, India

PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India

View Trial Details

Active, Not Recruiting

The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer

NCT07252297

Conditions: Carcinoma, Disease, Female Urogenital Diseases, +16 more
Locations: Xi Jing Hopspital Xi'an, ShannxI, China

View Trial Details

Active, Not Recruiting

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

NCT05696444

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +40 more
Locations: City of Hope Duarte, California, United States

University of Chiago Chicago, Illinois, United States

Mount Sinai New York, United States

Duke Medical Center Durham, North Carolina, United States

View Trial Details

Urinary Bladder Diseases

Urinary Bladder Diseases trial results

Related conditions